Chargement en cours...
METOCLOPRAMIDE IS METABOLIZED BY CYP2D6 AND IS A REVERSIBLE INHIBITOR, BUT NOT INACTIVATOR, OF CYP2D6
1. Metoclopramide is a widely used clinical drug in a variety of medical settings with rare acute dystonic events reported. The aim of this study was to assess a previous report of inactivation of CYP2D6 by metoclopramide, to determine the contribution of various CYPs to metoclopramide metabolism, a...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4059401/ https://ncbi.nlm.nih.gov/pubmed/24010633 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/00498254.2013.835885 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|